ABOUT US
R&D
INVESTORS
서울사무소
> R&D > Pipeline > YBL-011
Back to Pipeline
• Synergistic effect when combined with anti-PD-1 and anti-PD-L1
• 3 times higher T cell activation compared to competitors
Remix Template